...
首页> 外文期刊>CES Medicina Veterinaira y Zooctecnia >Canine transmissible venereal tumor: expression of MDR-1, and TP53 and BCL-2 family genes and its implications in biological and therapeutic behavior
【24h】

Canine transmissible venereal tumor: expression of MDR-1, and TP53 and BCL-2 family genes and its implications in biological and therapeutic behavior

机译:犬传染性病:MDR-1,TP53和BCL-2家族基因的表达及其对生物学和治疗行为的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Transmissible venereal tumor (TVT) is a neoplasm of round cells with plasmocytoid or lymphocytoid appearance. The tumor presents several particularities, which have been the subject of numerous studies; however there still have investigations that need to be done. For example, a progressive increase of highly aggressive tumors with varying response to chemotherapy -including resistance- has been evidenced in recent years. There is scientific interest to understand these differences, allowing predicting possible clinical outcomes in affected dogs and increasingly searching adequate and individualized therapy. This review focuses on presenting possible implications of the expression of MDR-1 (P-glycoprotein), TP53, BCL-2, and BAX genes, regarding resistance to chemotherapy and/or the biologic behavior of TVT.
机译:可传播的性病(TVT)是具有胞浆状或淋巴细胞状外观的圆形细胞肿瘤。肿瘤具有几种特殊性,已经成为许多研究的主题。但是,仍然需要进行调查。例如,近年来已证明,对化学疗法具有不同反应(包括耐药性)的高度侵袭性肿瘤逐渐增加。了解这些差异,从而预测受影响的犬可能的临床结局,并日益寻求适当和个性化的治疗方法,具有科学兴趣。这篇综述着重介绍了MDR-1(P-糖蛋白),TP53,BCL-2和BAX基因的表达对化学疗法和/或TVT生物学行为的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号